Lincoln National Corp 10x Genomics, Inc. Transaction History

Lincoln National Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$36.08 - $54.3 $108 - $162	-3 Reduced -0.0%	150,205 $5.64 Million
Q4 2023 Feb 06, 2024	BUY	$34.32 - $57.55 $102 - $172	3 Added 0.0%	150,208 $8.41 Million
Q3 2023 Nov 03, 2023	BUY	$40.86 - $62.98 $367 - $566	9 Added 0.01%	150,205 $6.2 Million
Q2 2023 Aug 04, 2023	SELL	$50.96 - $58.72 $509 - $587	-10 Reduced 0.01%	150,196 $8.39 Million
Q1 2023 May 01, 2023	SELL	$35.33 - $55.79 $706,600 - $1.12 Million	-20,000 Reduced 11.75%	150,206 $8.38 Million
Q4 2022 Feb 07, 2023	SELL	$24.4 - $41.3 $973,974 - $1.65 Million	-39,917 Reduced 19.0%	170,206 $6.2 Million
Q1 2022 May 09, 2022	SELL	$55.7 - $145.79 $4,790 - $12,537	-86 Reduced 0.04%	210,123 $16 Million
Q4 2021 Jan 26, 2022	BUY	$135.05 - $182.59 $28.4 Million - $38.4 Million	210,209 New	210,209 $31.3 Million

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.